To compare the recovery time of Propofol or Isoflurane in day case procedures by Ajay Kumar, A
                                            Dissertation on
TO COMPARE THE RECOVERY TIME OF PROPOFOL OR 
ISOFLURANE IN DAY CASE PROCEDURES.
Dissertation Submitted in partial fulfillment of
M.D. DEGREE EXAMINATION
BRANCH X – ANAESTHESIOLOGY
MADRAS MEDICAL COLLEGE, CHENNAI.
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY
CHENNAI, TAMIL NADU
MARCH 2007
Declaration
I hereby declare that dissertation entitled “TO COMPARE THE RECOVERY 
TIME OF PROPOFOL OR ISOFLURANE IN DAY CASE PROCEDURES”, has 
been prepared by me under the guidance of PROF.DR.G.SIVARAJAN, M.D., D.A Professor 
and  Head  of  Department  of  Anaesthesiology,  Madras  Medical  College,  Chennai  in 
partial  fulfillment  of  the  regulations  for  the  award  of  the  degree  of  M.D. 
(Anaesthesiology), examination to be held in March 2007.
 This study was conducted at Madras Medical College and Government General 
Hospital, Chennai.
I have not submitted this dissertation previously to any university for the award of 
any degree or diploma. 
Date:
Place: Chennai. Dr. A. Ajay Kumar
CERTIFICATE
This  is  to  certify  that  the  Dissertation  “TO COMPARE THE RECOVERY 
TIME  OF  PROPOFOL  OR  ISOFLURANE  IN  DAY  CASE 
PROCEDURES.” presented herein by Dr. A. Ajay Kumar is an original work done in the 
Department  of  Anaesthesiology,  Madras  Medical  College  and  Government  General  Hospital, 
Chennai for the award of Degree of M.D. (Branch X) Anaesthesiology under my guidance and 
supervision during the academic period of 2004-2007.
Place:                                                  Prof.Dr.G.Sivarajan, MD., DA., 
Date:                                                   Professor & HOD,
Department of Anesthesiology,
Madras Medical College & Hospital,
Chennai.
      
CERTIFICATE
This  is  to  certify  that  the  Dissertation “TO COMPARE THE RECOVERY 
TIME  OF  PROPOFOL  OR  ISOFLURANE  IN  DAY  CASE 
PROCEDURES.” presented herein by Dr. A. Ajay Kumar is an original work done in the 
Department  of  Anaesthesiology,  Madras  Medical  College  and  Government  General  Hospital, 
Chennai for the award of Degree of M.D. (Branch X) Anaesthesiology during the academic period 
of 2004-2007.
Place:                                                                                  Prof.Dr.Kalavathy Ponniraivan, B.Sc, MD.,
              Date:                                                                                                                                                  DEAN,
                            Madras Medical College & Hospital,
    Chennai.
ACKNOWLEDGEMENT
I wish to express my sincere thanks to Prof. Dr. Kalavathy Ponniraivan, MD., Dean, Madras 
Medical College, Chennai for having kindly permitted me to utilize the hospital facilities to conduct 
this study.
           I express my deep sense of gratitude to Prof. Dr. G. Sivarajan, M.D., D.A., Professor & Head 
of  the  Department  of  Anaesthesiology,  Madras  Medical  College,  Chennai  for  his  constant 
encouragement and invaluable guidance.
           My  sincere  thanks  to Prof.  Dr.  S.  Gayathri, M.D.,  D.A.,  Additional  Professor  of 
Anaesthesiology, for her continuous supervision and able guidance throughout this work.
           My sincere  thanks  to Prof.  Dr.  A.  Thiruselvam,  M.D.,  D.A.,  Additional  Professor  of 
Anaesthesiology, for his instructions and suggestions.
           My sincere thanks to  Prof. Dr. Kamalini Sridharan,  M.D., D.A., Additional Professor of 
Anaesthesiology, for her valuable suggestions and support. 
           I am very grateful to Dr.T. Venkatachalam, M.D., D.A., Registrar/ Lecturer, for his patience 
and kind co-operation during the preparation of this dissertation.
           I express my heart-felt gratitude to my guide Dr.N. Latha, M.D., D.A., Assistant professor, for 
his constant guidance and invaluable help in every step of this study.
I  thank all  the Assistant  Professors  and Tutors for their  able  help,  support  and supervision 
during the course of the study. 
I also express my thanks to all my colleagues for their co-operation and support for this study.
I  thank all  the patients  included in the study and their  relatives, for their  wholehearted co-
operation in spite of their illness.
Last but not the least; I would like to express my sincere gratitude to Lord Almighty. 
 
           
INDEX
Page No.
1. INTRODUCTION 1
2. AIM OF STUDY 4
3. AMBULATORY ANESTHESIA 5
4. PHARMACOLOGY OF PROPOFOL 7
5. PHARMACOLOGY OF ISOFLURANE 12
6. TOTAL INTRAVENOUS ANESTHESIA 21
7. LARYNGEAL MASK AIRWAY 25
8. ASSESSMENT OF RECOVERY 30
9. REVIEW OF LITERATURE 35
10.MATERIALS AND METHODS 39
11.OBSERVATIONS AND RESULTS 44
12.DISCUSSION 47
13.SUMMARY 52
14.CONCLUSION 53
BIBLIOGRAPHY
PROFORMA
MASTER CHART
INTRODUCTION
A surgical  procedure  performed on  a  patient  admitted  and discharged on the  same  day of 
surgery is an accepted and well-established practice in modern medicine today. The several names, 
debated and revised over several years are Day Case, Day Care, Day Surgery, Ambulatory Surgery, 23-
hours surgery, and OPD procedures.
The history of Day Care surgery is from time immemorial, as old as medicine itself, changing 
with the times and needs, to reach the present status. The great surgeon Sushruth has done many of his 
surgeries probably as day care surgery even before hospitals were well established. The establishment 
of hospitals and ambulatory units was popularized by Ashoka the Great.
In 1909, Mac Nicoll published a large series of 7000 cases done as Day care procedures. He 
found that recovery was better in children when they are allowed to recoup at home. Around that time, 
surgeons and hospital administrators found hospitalization to be more beneficial to patients’ recovery, 
in terms of prevention of post-operative infection. And thus Day care surgery suffered a set back. With 
the advent of better antibiotics and asepsis, Day Care surgery was revived during the 40’s and 50’s, but 
the major bulk of work was done in the 70’s and 80’s, which permanently established Day Care surgery 
as part of medical care. 
With the invention of better anaesthetic agents, Day surgeries received a much needed boost, 
where it was found unnecessary to keep the patient back in the hospital.
There were several factors, indigenous to each country, which have encouraged innovations in 
day surgeries. The Americans introduced medical insurance since the cost of medical care could no 
longer be borne by average person. The insurance companies forced the medical care specialist to cut 
costs and made him think and thus, adapt the benefits of Day Care surgery. In U.K., the long wait list, 
where patients had to wait for several years for surgeries, where National Health Scheme could not 
cope-up with the work load, Day care solved the problem.
In India, where medical insurance is yet to come up, we find a mixture of both the problems. 
Day Surgery, which has evolved into an art form, is nowadays being practiced more widely. 
The principal arguments in favour of this practice are minimizing cost and making hospital 
resources available for more number of patients, as each patient spends a shorter period in the hospital. 
A shorter stay in the hospital also means lesser disruption in the regular activities of the patient and his 
relatives and lesser chances of nosocomial infections. It also decreases the patients’ separation from 
their familiar home environment making it preferable to the children and elderly. 
Ambulatory anaesthesia was conceptualized by Ralph Waters in the early 1900s, and has grown 
at an exponential rate in the past three decades. Initially the anaesthetic techniques used were regional 
techniques, but many patients nowadays request for general anaesthesia. Earlier, general anaesthesia 
drugs had prolonged recovery times making it unsuitable for day case procedures. The availability of 
shorter acting anaesthetic agents with better recovery profile has made general anaesthesia applicable 
in day case procedures. The ‘clear headedness’ of recovery enables the patients to be discharged from 
the hospital just a few hours after surgery. 
    
Two such drugs found most suitable for this technique are Propofol and Isoflurane. The 
present  study compares  the recovery characteristics  of  these two drugs  and their  usefulness  in 
ambulatory anaesthesia.
AIM OF THE STUDY
The aim of the study is to compare the recovery times when Propofol or Isoflurane are used 
for  the  maintenance  of  anaesthesia  in  day case  surgery and also  to  determine  which  agent  is 
suitable to make the patient home fit at the earliest.
AMBULATORY ANESTHESIA
Today the majority of patients who undergo minor surgery or diagnostic tests do not need to 
stay overnight in the hospital. In most cases, the patients will be well enough to complete the recovery 
at home. Ambulatory (or outpatient) anesthesia and surgical care has proven to be safe, convenient and 
cost-effective and can be performed in a variety of facilities. The surgery may be done in a hospital, a 
freestanding surgery center or, in some cases, a surgeon’s office. Anesthesia care is given or supervised 
by an anesthesiologist.4
Ambulatory anesthesia is tailored to meet the needs of ambulatory surgery so that the patient 
can  go  home  soon  after  the  operation.  Short-acting  anesthetic  drugs  and  specialized  anesthetic 
techniques as well as care specifically focused on the needs of the ambulatory patient are used to make 
the experience safe and pleasant. In general, if the patient is in reasonably good health, he/she is a 
candidate for ambulatory anesthesia and surgery. After the early recovery from anesthesia, the patient 
can  go  home  directly.  In  most  cases,  family  and  friends  can  provide  all  the  needed  assistance. 
Appropriate pain management is included as part of the discharge planning.1, 4
There are several types of anesthetic techniques available for ambulatory surgery ranging from 
local  anesthesia  to  general  anesthesia.  The  anesthetic  technique  recommended depends  on  several 
factors. In some cases,  the surgical  procedure will  dictate what kind of anesthesia will  be needed. 
Based on the medical history, a type of anesthetic may have an additional margin of safety. As an 
outpatient, some techniques may allow the patient to recover more quickly with fewer side effects. The 
patients’ preferences are also incorporated in the selection of the best anesthetic plan for the procedure.
The four anesthetic options are:
• General anesthesia 
• Regional anesthesia 
• Monitored anesthesia care 
• Local anesthesia 
General  anesthesia  with  regional  anesthesia  for  post  operative  pain  relief  is  an  ideal 
combination as it combines the advantages of both – the comfort and lack of awareness in the former 
and the good quality of pain relief with the latter.
PHARMACOLOGY OF PROPOFOL
Propofol1 is  a  substituted  isopropyl  phenol  chemically  2,6-diisopropyl  phenol.  It  is 
administered intravenously as a 1% solution in an aqueous solution of 10% soybean oil, 2.25% 
glycerol and 1.2% purified egg phosphatide. This drug is chemically distinct from all other drugs 
that act as Intravenous Sedative Hypnotics. Administration of Propofol 1.5 to 2.5 mg/Kg IV as a 
rapid  intravenous  injection  (<15secs)  produces  unconsciousness  within  about  30  seconds. 
Awakening is more rapid and complete than that after induction of anaesthesia with all other drugs. 
The more rapid return of consciousness with minimal residual central nervous system effects is one 
of the most important advantages of Propofol.
Mechanism of Action:
Propofol  is  presumed  to  exert  its  sedative  hypnotic  effects  through an  interaction  with 
GABA,  the  principal  inhibitory  neurotransmitter  in  the  central  nervous  system.  When  GABA 
receptor is activated, transmembrane Chloride conductance increases, resulting in hyperpolarisation 
of  the post synaptic  cell  membrane and functional  inhibition of the post  synaptic  neuron.  The 
interaction  of  Propofol  with  specific  components  of  the  GABA  receptor  complex  appears  to 
decrease the rate of dissociation of GABA from its receptor, thereby increasing the duration of the 
GABA  activated  opening  of  the  Chloride  channel  with  resulting  hyperpolarisation  of  cell 
membranes.
Pharmacokinetics:
Hepatic  metabolism  and  tissue  uptake  (possibly  into  the  lungs)  are  both  important  in 
removal of this drug from the plasma. Hepatic metabolism is rapid and extensive,  resulting in 
inactive, water-soluble sulfate and glucuronic acid conjugates that are excreted by the kidneys. The 
elimination halftime is 0.5 to 1.5 hours, but more important, the context-sensitive half-time for 
Propofol infusions lasting up to 8 hours is <40 minutes. The context-sensitive half-time of Propofol 
is minimally influenced by the duration of the infusion because of rapid metabolic clearance when 
the infusion is discontinued, such that drug that returns from tissue storage sites to the circulation is 
not available to retard the decrease in plasma concentrations of the drug.
There is no evidence of impaired elimination in patients with cirrhosis of liver or renal 
dysfunction.
Volumes of distribution:
Initial apparent (Vol D): 13 to 76 L.
Steady-state (Vol DSS): 171 to 349 L.
Elimination (Vol D): 209 to 1008 L
Pharmacodynamics:
Haemodynamic effects:
Propofol's  haemodynamic  effects  are  generally  more  pronounced  than  those  of  other 
intravenous anaesthetic agents. Arterial hypotension, with readings decreased by as much as 30% 
or more, has been reported, possibly due to inhibition of sympathetic vasoconstrictor nerve activity. 
Hypotensive effects are generally proportional to dose and rate of administration of Propofol, and 
may be potentiated by opioid analgesics.  Endotracheal intubation and surgical  stimulation may 
increase arterial  pressure. Increases in heart  rate and/or blood pressure to greater than baseline 
values, which occur frequently with other agents, are not as significant with Propofol. This may be 
due  to  central  sympatholytic  and/or  vagotonic  effects.  Propofol  may  also  decrease  systemic 
vascular resistance,  myocardial  blood flow, and oxygen consumption.  The mechanism of these 
effects may involve direct  vasodilation and negative inotropy. Effects such as decreased stroke 
volume and cardiac output have been demonstrated in some studies.
Respiratory effects:
Propofol  is  a  respiratory  depressant,  frequently  producing  apnoea  that  may  persist  for 
longer than 60 seconds, depending on factors such as premedication, rate of administration, dose 
administered, and presence of hyperventilation or hyperoxia. In addition, Propofol may produce 
significant decreases in respiratory rate, minute volume, tidal volume, mean inspiratory flow rate, 
and  functional  residual  capacity.  These  respiratory  depressant  effects  may  be  the  result  of 
depression of the central inspiratory drive as opposed to a change in central timing. The ventilatory 
depressant effects of Propofol may be counteracted by painful surgical stimulation.
Cerebral effects:
Propofol decreases  cerebral  blood  flow,  cerebral  metabolic  oxygen  consumption,  and 
intracranial  pressure.  It  also  increases  cerebrovascular  resistance  but  does  not  appear  to  affect 
cerebrovascular reactivity to changes in arterial carbon dioxide tension.
Other effects:
Preliminary findings  suggest  that  in  patients  with normal  intraocular  pressure,  Propofol 
decreases intraocular pressure by as much as 30 to 50%. This decrease may be associated with a 
concomitant decrease in systemic vascular resistance.
Clinical  studies have shown that Propofol does not cause significant signs of histamine 
release  or  significant  increases  in  plasma  immunoglobulin  or  complement  C 3  levels.  Airway 
resistance after tracheal intubation is lower when Propofol is used for induction of anaesthesia than 
when Thiopental or high-dose Etomidate is used.
Although Propofol has the potential for affecting adrenal steroidogenesis, it does not appear 
to block cortisol and aldosterone secretion in response to surgical  stress or adrenocorticotropic 
hormone  (ACTH)  in  clinical  practice.  Although  transient  decreases  in  plasma  cortisol 
concentrations have occurred, these reductions have not been sustained.
Propofol  appears  to  have  no  analgesic  activity.  In  addition,  animal  studies  have 
demonstrated no significant  effect on coagulation profiles. Limited experience with Propofol in 
susceptible  patients  and animal  studies  has  not  demonstrated a  propensity to  induce malignant 
hyperthermia.
Clinical Uses:
Induction of Anaesthesia:
The induction dose of Propofol in healthy adults is 1.5 to 2.5mg/Kg Intravenous, with blood 
levels  of  2-6µg/mL  producing  unconsciousness  depending  on  associated  medications  and  the 
patient’s age. Awakening typically occurs at plasma concentrations of 1 to 1.5µg/mL.
Maintenance of Anaesthesia:
The typical dose of Propofol for maintenance of anaesthesia is 100 to 300µg/Kg/Minute 
I.V,  often  in  combination  with  a  short  acting  opioid.  General  Anaesthesia  with  Propofol  is 
generally associated with minimal Post Operative Nausea Vomiting and awakening is prompt with 
minimal residual sedative effects.
PHARMACOLOGY of ISOFLURANE
Isoflurane1 (1-chloro-2, 2, 2-trifluoroethyl difluoromethyl ether) is a halogenated ether used 
for inhalation anaesthesia. 
Physical properties:
-Molecular weight 184.5 g/mol
-Boiling point (at 1 atm): 48.5 °C
-Density (at 25 °C): 1.496 g/mL
-MAC: 1.15 volumes %
-Vapour pressure: 238 mmHg 31.7 kPa (at 20°C)
-Blood: Gas Partition coefficient: 1.4
-Oil: Gas Partition coefficient: 98
 
Mechanism of Action of Inhaled Anaesthetics3 
Inhaled anaesthetics act in different ways at the level of the central nervous system. They 
may disrupt normal synaptic transmission by interfering with the release of neurotransmitters from 
presynaptic nerve terminal (enhance or depress excitatory or inhibitory transmission), by altering 
the  re-uptake  of  neurotransmitters,  by  changing  the  binding  of  neurotransmitters  to  the  post-
synaptic receptor sites, or by influencing the ionic conductance change that follows activation of 
the  post-synaptic  receptor  by neurotransmitters.  Both,  pre-  and  postsynaptic  effects  have  been 
found.
Direct interaction with the neuronal plasma membrane is very likely, but indirect action via 
production  of  a  second  messenger  also  remains  possible.  The  high  correlation  between  lipid 
solubility and anaesthetic potency suggests that inhalation anaesthetics have a hydrophobic site of 
action. Inhalation agents may bind to both membrane lipids and proteins. It is at this time not clear 
which of the different theories are most likely to be the main mechanism of action of inhalation 
anaesthetics.
The  Meyer-Overton  theory describes  the  correlation  between lipid  solubility of  inhaled 
anaesthetics and MAC and suggests that anaesthesia occurs when a sufficient number of inhalation 
anaesthetic molecules dissolve in the lipid cell membrane. The Meyer-Overton rule postulates that 
the number of molecules dissolved in the lipid cell membrane and not the type of inhalation agent 
causes anaesthesia. Combinations of different inhaled anaesthetics may have additive effects at the 
level of the cell membrane.
However,  the Meyer-Overton theory does not describe why anaesthesia  occurs.  Mullins 
expanded the Meyer-Overton rule by adding the so-called Critical Volume Hypothesis. He stated 
that the absorption of anaesthetic molecules could expand the volume of a hydrophobic region 
within the cell membrane and subsequently distort channels necessary for sodium ion flux and the 
development of action potentials  necessary for synaptic  transmission.  The fact  that  anaesthesia 
occurs  with  significant  increase  in  volume  of  hydrophobic  solvents  and  is  reversible  by 
compressing  the  volume  of  the  expanded  hydrophobic  region  of  the  cell  membrane  supports 
Mullins Critical Volume Hypothesis.
The  protein  receptor  hypothesis  postulates  that  protein  receptors  in  the  central  nervous 
system  are  responsible  for  the  mechanism  of  action  of  inhaled  anaesthetics.  This  theory  is 
supported by the steep dose response curve for inhaled anaesthetics. However, it remains unclear if 
inhaled agents disrupt  ion flow through membrane channels  by an indirect  action on the lipid 
membrane, via a second messenger, or by direct and specific binding to channel proteins.
Another theory describes the activation of Gamma-Amino Butyric Acid (GABA) receptors 
by the inhalation anaesthetics. Volatile agents may activate GABA channels and hyperpolarize cell 
membranes. In addition, they may inhibit certain calcium channels and therefore prevent release of 
neurotransmitters  and inhibit  glutamate channels.  Volatile  anaesthetics  share therefore common 
cellular actions with other sedative, hypnotic or analgesic drugs.
The true mechanism of action of volatile anaesthetics may be a combination of two or more 
such theories described as multisite action hypothesis.
Pharmacokinetics:
Uptake and distribution of inhaled anaesthetics3
A series of partial pressure gradients, beginning at the vaporizer of the anaesthetic machine, 
continuing in the anaesthetic breathing circuit, the alveolar tree, blood, and tissue will ensure the 
forward movement of the gas. The principal objective of that movement is to achieve equal partial 
pressures on both sides of each single barrier.  The alveolar partial  pressure governs the partial 
pressure of the anaesthetic in all body tissues; they all will ultimately equal the alveolar partial 
pressure of the gas. After a short period of equilibration the alveolar partial pressure of the gas 
equals  the  brain  partial  pressure.  Alveolar  partial  pressure  can  be  raised  by increasing  minute 
ventilation, flow rates at the level of the vaporizer and by using a non-rebreathing circuit.
Two special effects increasing the amount of gas in the alveoli have to be mentioned. The 
Concentration effect describes how the concentration of the gas in the remaining alveolar volume 
can increase after  some of the gas has been transferred into the blood. The Second gas effect 
usually refers to nitrous oxide combined with an inhalation agent. Because nitrous oxide is not 
soluble  in  blood,  its  rapid  absorption  from  alveoli  causes  an  abrupt  rise  in  the  alveolar 
concentration of the other inhalation anaesthetic. All the above mentioned factors influence the 
inflow of gas into the alveoli.
Solubility, cardiac output, and the alveolar to venous anaesthetic gradient represent outflow 
factors. Inflow factors minus outflow factors equal alveolar partial pressure of the gas.
Solubility describes the affinity of the gas for a medium such as blood or fat tissue. The 
blood/gas partition coefficient describes how the gas will partition itself between the two phases 
after equilibrium has been reached. Isoflurane for example has a blood/gas partition coefficient of 
1.4. This means that if the gas is in equilibrium the concentration in blood will be 1.4 times higher 
than the concentration in the alveoli. A higher blood gas partition coefficient means a higher uptake 
of the gas into the blood and therefore a slower induction time. It takes longer until the equilibrium 
with the brain partial pressure of the gas is reached.
A higher  cardiac output  removes  more volatile  anaesthetic  from the alveoli  and lowers 
therefore the alveolar partial pressure of the gas. The agent might be faster distributed within the 
body but the partial pressure in the arterial blood is lower. It will take longer for the gas to reach 
equilibrium between the alveoli and the brain. Therefore, a high cardiac output prolongs induction 
time.
The  alveolar  to  venous  partial  pressure  difference  reflects  tissue  uptake  of  the  inhaled 
anaesthetics.  A large difference is  caused by increased uptake of  the gas during the induction 
phase. This facilitates the diffusion of the gas from the alveoli into the blood.
The brain/blood coefficient  describes  how the  gas  will  partition  itself  between the  two 
phases after equilibrium has been reached. Isoflurane for example has a brain/blood coefficient of 
1.6 meaning that if the gas is in equilibrium the concentration in the brain will be 1.6 times higher 
than  the  concentration  in  the  blood.  All  inhalation  anaesthetics  have  high  fat/blood  partition 
coefficients. This means that most of the gas will bind to fatty tissue as times goes by. The partial 
pressure of the gas in fatty tissue will rise very slowly. Inhalation anaesthetics stored in such tissue 
in obese patients may delay awakening at the end of anaesthesia.
Isoflurane shows very low solubility in blood and body tissues. Thus its partial pressure 
(concentration)  in  alveolar  gas  or  arterial  blood  rises  to  50% of  the  inspired  partial  pressure 
(concentration) within 4-8 minutes of the start of its inhalation, and to 60% within 15 minutes. 
Throughout  maintenance  of  anaesthesia,  a  high  proportion  of  the  Isoflurane  inspired  is 
eliminated by the lungs. When administration is stopped and inspired concentration becomes zero, 
the bulk of the remaining Isoflurane is eliminated unchanged from the lungs. In keeping with its 
low solubility, recovery from Isoflurane anaesthesia in man is rapid.
Biotransformation of Isoflurane is significantly less than that of Enflurane or Halothane. 
Humans  biotransform a  small  fraction  of  Isoflurane  administered.  In  man  about  0.2% of  the 
Isoflurane administered, is evident as recoverable metabolites (fluoride and organic fluorine), with 
approximately 50% of these excreted in the urine, the principal metabolite being trifluoracetic acid.
Enzyme induction associated with pre-existing drug therapy would not appear  to be an 
important factor in the metabolism of Isoflurane in man, mainly because the overall metabolism of 
Isoflurane is so low.
Dosage and Administration:
Isoflurane has a slight pungent ethereal odour, which may limit the rate of gas induction 
but, despite this, induction and particularly recovery are rapid. Salivation and tracheo-bronchial 
secretions  may  be  stimulated  in  children  but  pharyngeal  and  laryngeal  reflexes  are  quickly 
diminished. 
Induction:
As Isoflurane has a mild pungency, inhalation should usually be preceded by the choice of a 
short-acting barbiturate, or other intravenous induction agent, to prevent coughing. Alternatively, 
Isoflurane  with  oxygen  or  an  oxygen/nitrous  oxide  mixture  may  be  administered.  It  is 
recommended that induction with Isoflurane be initiated at a concentration of 0.5%. Concentrations 
of 1.5-3.0% usually produce surgical anaesthesia in 7-10 minutes. Blood pressure decreases during 
induction but this may be compensated by surgical stimulation.
Maintenance:
Adequate  anaesthesia  for  surgery  may  be  sustained  with  an  inspired  Isoflurane 
concentration  of  1.0%  -  2.5%  in  an  oxygen/70%  nitrous  oxide  mixture.  Additional  inspired 
Isoflurane (0.5% - 1%) will be required with lower nitrous oxide levels, or when Isoflurane is given 
with  oxygen  alone  or  air/oxygen  mixtures.  Blood  pressure  decreases  during  maintenance 
anaesthesia in relation to the depth of anaesthesia. That is, blood pressure is inversely related to the 
Isoflurane concentration. Provided there are no other complicating factors this is probably due to 
peripheral vasodilation. Cardiac rhythm remains stable. Excessive falls in blood pressure may be 
due to the depth of anaesthesia and in such circumstances can be corrected by reducing the inspired 
Isoflurane concentration.
Recovery:
The concentration of Isoflurane can be reduced to 0.5% at the start of closing the operation 
wound, and then to 0% at the end of surgery. After discontinuation of all anaesthetics, the airways 
of the patient should be ventilated several times with oxygen 100% until complete recovery.
TOTAL INTRAVENOUS ANESTHESIA
History:
TIVA2 was first conducted by a French man Pierre Oré in Lyons in 1874 to investigate the 
effects  of  anaesthesia  induced  with  intravenous  Chloral.  The  incidence  of  morbidity  was 
unacceptable  and the  technique  fell  into  disrepute.  In  1932,  intravenous  anaesthesia  became a 
serious prospect following the introduction of Hexobarbitone and Thiopentone, first used by Ralph 
Waters,  but  reported  initially  by John Lundy.  Methohexitone  appeared  in  1956  and has  been 
described as a sole agent for both induction and short term maintenance of anaesthesia. Propanidid, 
Althesin and Etomidate were also tried but are no longer available for human use. Ketamine was 
the first drug designed specifically for TIVA; although it fell into disrepute because in high doses it 
produced psycho mimetic effects. 
Because  of  its  favourable  pharmacokinetic  and  pharmacodynamic  profile,  Propofol  has 
become the most widely used intravenous anaesthetic for TIVA. Although many of the published 
studies  have  combined  Propofol  with  Alfentanyl  because  of  the  perceived  pharmacokinetic 
advantages of the latter over Fentanyl, Propofol can be combined with any Opioid.
Infusion schemes for Intravenous Anaesthesia: 2
The general principles of intravenous anaesthesia can be summarized:-
1. The induction dose of an intravenous anaesthetic agent should be sufficient to ensure that 
the patient loses consciousness, but not so great as to cause undesirable side effects such as 
arterial hypotension and bradycardia or tachycardia.
2. The  maintenance  infusion  scheme  should  allow  a  predetermined  arterial  blood 
concentration  of  the  drug,  sufficient  to  achieve  adequate  surgical  anaesthesia,  to  be 
achieved as quickly as possible and maintained reasonably constant at  the early part  of 
anaesthesia up to the surgical incision.
3. The maintenance infusion scheme must also be capable of alteration to decrease or increase 
the  arterial  blood  concentration  of  the  drug  to  match  the  requirements  of  continuing 
surgery.
SCHEMES:
Infusion schemes to achieve stable blood concentrations of intravenous drugs fall into four 
categories.
1. Zero-order infusions: Continuous infusions at a fixed rate.
2. Ramp infusion: Designed to have a constantly increasing rate of infusion for short periods 
of time.
3. Computer controlled infusions: Designed to achieve either a constant blood concentration 
or a constant brain concentration.
4. Manually controlled infusions: Stepped infusions to simulate the behaviour of a computer 
controlled infusion.
In this study, manually controlled stepped infusions were used.
MANUALY CONTROLLED STEPPED INFUSION SCHEMES
Roberts et aldevised a simple stepped scheme in which a loading dose was followed by 
three stepped infusions designed to simulate the exponential decrease of the infusion rate in the 
BET scheme. This scheme is very simple to operate, requires no computer, and apart from minor 
deviations  within  the  first  20  minutes  of  the  infusion,  produces  predictable  blood  Propofol 
concentrations.
Staged Recipes Propofol TIVA 2, 14
Propofol:
–Initial bolus 2mg/kg IV
–12 mg/kg/h x 10 min (200 mcg/kg/min)
–10 mg/kg/h x 20 min (167 mcg/kg/min)
–8 mg/kg/h x 1 h   (133 mcg/kg/min)
–6 mg/kg/h maintenance (100 mcg/kg/min)
– (awareness at 18 mcg/kg/min)
Add Narcotic bolus or infusion of choice.
TARGET CONTROLLED INFUSION
Progress in computing technology has allowed the development of target controlled infusion 
devices, with drugs delivered to achieve specific predicted target blood drug concentrations. Target 
controlled infusion (TCI) system has been found to be ideal for the administration of Propofol for 
TIVA.  A set of pharmacokinetic parameters is selected using computer simulation of a known infusion 
scheme. The selected model is incorporated into a computer-compatible infusion pump.
 Clinical  trials  with  such  systems  have  provided  appropriate  target  concentrations  for  the 
administration  of  target  controlled  infusion  of  anaesthetic  drugs.  Nowadays  TCI  technology  is 
becoming a part of routine anesthesia technique especially in intravenous anesthesia. Besides clinical 
application in anesthesia, target controlled systems are also being researched for the administration of 
sedative and analgesic drugs in the peri-operative period.
Laryngeal Mask Airway
The laryngeal mask airway (LMA) 5 is a supra glottic airway device used in anaesthesia and in 
emergency medicine for airway management. It was invented in the 1980s by British anaesthetist, Dr. 
Archie Brain. It is a tube with an inflatable cuff that is inserted into the pharynx. It sits tightly over the 
top  of  the  larynx.  Post  operatively  it  causes  less  pain  and  coughing  than  an  endotracheal  tube. 
However, it does not protect the lungs from aspiration, making it unsuitable for anybody at risk of this 
complication
The  laryngeal  mask  airway  avoids  tracheal  intubation  and  can  be  used  with  spontaneous 
respiration or artificial ventilation. It has found favour in day case surgery.
Clinical benefits:
• More secure than a face mask 
• Allows single-handed ventilation 
• Rapid, blind insertion (no laryngoscopy)
Indications: 
• Routine and emergency anaesthetic procedures 
• Known or unexpected difficult airways 
• Establishing an airway during resuscitation in the profoundly unconscious patient with absent 
glossopharyngeal and laryngeal reflexes when tracheal intubation is not possible
Contraindications: 
• Patients who are not fasted or where fasting cannot be confirmed
• May have retained gastric contents
• Have fixed decreased pulmonary compliance
TECHNIQUE OF LMA INSERTION
Before insertion:-
• Step 1: Size selection
• Step 2: Examination of the LMA
• Step 3: Check deflation and inflation of the cuff
• Step 4: Lubrication of the LMA
• Step 5: Position the Airway
STEP I – Size selection
• To verify that the size of the LMA is correct for the patient
• Recommended Size guidelines:
• Size 1: • under 5 kg
• Size 1.5: • 5 to 10 kg
• Size 2: • 10 to 20 kg
• Size 2.5: • 20 to 30 kg
• Size 3: • 30 kg to small adult
• Size 4: • adult
• Size 5: Large adult/poor seal with size 4
STEP II - Examination of the LMA
• The LMA is visually inspected for cuff tears or other abnormalities.
• The shaft is checked to ensure that it is free of blockage or loose particles
• Next the cuff is checked by deflating to ensure that it will maintain a vacuum and inflating to 
ensure that it does not leak
STEP III - Checking deflation and inflation of the cuff
• The cuff is slowly deflated to form a smooth flat wedge shape which will pass easily around the 
back of the tongue and behind the epiglottis.
• During inflation the maximum air in cuff should not exceed:
• Size 1: • 4 ml
• Size 1.5: • 7 ml
• Size 2: • 10 ml
• Size 2.5: • 14 ml
• Size 3: • 20 ml
• Size 4: • 30 ml
• Size 5: • 40 ml
STEP IV - Lubrication of the LMA
• A water soluble lubricant is used to lubricate the LMA just prior to insertion.
• The back of the mask is thoroughly lubricated. 
• An excessive amount of lubricant on the anterior surface of the cuff or in the bowl of the mask 
is avoided as inhalation of the lubricant following placement may result in coughing or 
obstruction.
STEP V - Positioning the Airway
• The head is extended and the neck flexed.
LMA Insertion
The LMA is grasped by the tube, holding it like a pen as near as possible to the mask end. The 
tip of the LMA is placed against the inner surface of the patient’s upper teeth and under direct vision; 
the mask tip is pressed upwards against the hard palate to flatten it out. The index finger keeps pressing 
upwards as the mask is advanced into the pharynx to ensure the tip remains flattened and avoids the 
tongue. Keeping the neck flexed and head extended, the mask is pressed into the posterior pharyngeal 
wall using the index finger. 
Continuous pushing with the index finger guides the mask downward into position. The tube is 
grasped firmly with the other hand before withdrawing the index finger from the pharynx. Pressing 
gently downward with the other hand ensures that the mask is fully inserted. Next, the mask is 
inflated with the recommended volume of air. 
One should avoid over-inflating the LMA as it can result in loss of seal. It is preferable not 
touch the LMA tube while it is being inflated unless the position is obviously unstable. Normally the 
mask rises up slightly out of the hypopharynx as it is inflated to find its correct position. 
Verification of placement of the LMA
The LMA is connected to a Bag-Valve Mask device or low pressure ventilator. The patient is 
ventilated  while  confirming equal  breath  sounds  over  both  lungs  in  all  fields  and the  absence  of 
ventilatory sounds over the epigastrium.
Securing the LMA
A bite-block or roll of gauze is inserted to prevent occlusion of the tube should the patient bite 
down. Now the LMA is secured utilizing the same techniques as those employed in the securing of an 
endotracheal tube.
Problems with LMA Insertion
Failure  to  press  the  deflated  mask  up  against  the  hard  palate  or  inadequate  lubrication  or 
deflation can cause the mask tip to fold back on itself. Once the mask tip has started to fold over, this 
may progress, pushing the epiglottis into its down-folded position causing mechanical obstruction. 
If the mask tip is deflated forward it can push down the epiglottis causing obstruction. 
If the mask is inadequately deflated it may either push down the epiglottis or penetrate the 
glottis.
Assessment of Recovery and Home Readiness
For any day care procedure, the assessment of recovery is of paramount significance. A 
discrete  time interval  is  no longer  considered crucial  for  discharge;  however,  the  patient  must 
achieve clinical criteria that clearly reflect passage through the phases of early and intermediate 
recovery. The new short acting anaesthetics and analgesics have been instrumental in the faster 
patient recovery now seen after surgery. Some patients are now being transferred directly from the 
operating table to the step-down unit (Phase 2 recovery), bypassing the PACU. This process is 
known as ‘fast-tracking’.1
Stages of Recovery:
There  are  three  stages  of  recovery  following  ambulatory  surgery,  namely,  Early, 
Intermediate and Late. Early and intermediate recovery stages occur in the ambulatory surgical 
facility, whereas late recovery refers to the resumption of normal daily activities and occurs after 
discharge.
Early recovery is the time interval during which patients emerge from anaesthesia, recover 
their protective reflexes and resume motor activity.  During this phase of recovery,  patients are 
cared for in a Phase I Post Anaesthesia Care Unit (PACU), where their vital signs and oxygen 
saturation  are  carefully  monitored  and  supplemental  oxygen,  analgesia  or  antiemetics  may be 
administered. The Aldrete score is commonly used to assess the fitness of patients to be transferred 
to the Phase II recovery area.
Postanaesthesia Recovery Score (Aldrete Score) 
ACTIVITY
2=Moves all extremities voluntarily or on command
1=Moves two extremities
0=Unable to move extremities
RESPIRATION
2=Breathes deeply & coughs freely
1=Dyspneic
0=Apneic
CIRCULATION
2=BP ± 20mm of preanaesthetic level
1=BP ± 20 to 50mm of preanaesthetic level
0=BP ± 50mm of preanaesthetic level
CONSCIOUSNESS
2=Fully awake
1=Arousable on calling
0=Not responding
OXYGEN SATURATION
2=SpO2 > 92% on room air
1=Supplemental O2 req to maintain SpO2>92%
0=SpO2 < 92% with O2 supplementation
Total score=10 (≥ 9 for PACU Bypass)
The late recovery period starts when the patient is discharged home and continues until full, 
functional recovery is achieved and the patient is able to return to work. The surgical procedure 
itself has the highest impact on the full functional recovery.
Fast Tracking:
The availability of rapid and short acting anaesthetic drugs for the maintenance of General 
Anaesthesia has facilitated the early recovery of outpatients after ambulatory surgical procedures. 
Patients may be completely awake and oriented, breathing comfortably, with stable vital signs at 
the time they leave the operating theatre after brief ambulatory surgical procedures done under 
General  Anaesthesia.  Significant  cost  savings  may  be  achieved  by  bypassing  the  PACU  – 
Personnel are the major cost of the PACU.
Assessment of Home Readiness:
Guidelines for safe discharge from ambulatory surgical facility include stable vital signs, 
return to baseline orientation, ambulation without dizziness, minimal pain and PONV, and minimal 
bleeding at the surgical site. All ambulatory surgical patients must have an escort to transport them 
home,  and they must  receive written  post  operative instructions  including advice  on whom to 
contact in case a problem develops. 
Causes of delay in discharge:
Delays  in  discharge  are  typically  related  to  persistent  symptoms  such  as  pain,  PONV, 
dizziness, unsteady gait or, frequently, the lack of an escort. Excessive pain post operatively is a 
common  surgery  related  cause  of  delayed  discharge.  Planning  an  appropriate  prophylactic 
analgesic helps to eliminate the delay due to inadequate post operative pain relief.
PADSS (Post Anaesthesia Discharge Scoring System)
A  discharge  scoring  system  has  been  developed  to  evaluate  and  document  patients’ 
readiness  for  discharge  objectively.  The  PADSS  is  a  simple  cumulative  index  that  measures 
patients’ home readiness and is based on five major criteria namely vital signs, activity, nausea & 
vomiting, pain and surgical site bleeding. 
A maximum score of 10 is possible. Patients achieving a score of 9 or greater and have a 
responsible adult escort are considered fit for discharge. The requirement of patients to drink and 
void prior to discharge may not be necessary.
(Modified PADSS) 1
VITAL SIGNS (BP & PR)
2=Within 20% of preoperative baseline
1=20% to 40% of preoperative baseline
0=>40% of preoperative baseline
A  MBULATION  
2=Steady gait, no dizziness, or preoperative level
1=Requires assistance
0=Unable to ambulate
NAUSEA & VOMITING
2=Minimal: treated with PO medication
1=Moderate: treated with IM medications
0=Continuous after repeated treatment
PAIN
Acceptable to pt; controlled with PO meds
2=Yes
1=No
SURGICAL BLEEDING
2=Minimal: no dressing change required
1=Moderate: up to two dressing changes
0=Severe: more than three dressing changes
Maximum score= 10 (≥ 9 required for discharge)
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MATERIALS AND METHODS
This  study was carried  out  in  the  General  Surgery theatre,  Government  General 
Hospital, Chennai after obtaining institutional approval. The aim of the study was to compare the 
Phase I and Phase II recovery times when Propofol or Isoflurane are used for the maintenance of 
anaesthesia  in day case procedures and also to  determine which agent  is  suitable  to  make the 
patient street fit at the earliest.
STUDY DESIGN
The study was a randomized prospective study.
SELECTION OF CASES
Forty patients  undergoing  Day Case  surgeries  in  the Head,  Breast  or  Upper  limb were 
selected for the study. Their age ranged from 18 to 47years. All the patients were assessed and 
those with normal clinical, biochemical radiological and haematological parameters were selected. 
Informed written consent was obtained from all the patients. Each patient was randomly allocated 
to either the Propofol or the Isoflurane group by lots. The groups were named ‘P’ for Propofol and 
‘I’ for Isoflurane.
INCLUSION CRITERIA
Assessed patients of ASA physical status I & II
Normal biochemical and haematological parameters
Age group between 18 to 50 years
ASA class I, II
No known hypersensitivity to eggs or sulpha drugs
Airway MPC 1, 2 and 3
Minor surgeries of head, neck, breasts and upper limb 
Surgery lasting less than 90 minutes duration
Patients normally able to ambulate well
Educated attender who can understand and carryout instructions
EXCLUSION CRITERIA
Patient not willing
ASA class III and above
Known hypersensitivity to eggs or sulpha allergy
Airway MPC IV
Major surgeries requiring overnight hospital stay
Surgeries near or involving the airway
Patient having difficulty in walking
No attender or attender not educated enough to carryout instruction
MATERIALS:
1. Boyles machine with Isoflurane vaporizer
2. Syringe infusion pump
3. Appropriate drugs in labelled preloaded syringes
4. Appropriate sized Laryngeal Mask Airways
5. Functioning Laryngoscope with appropriate size blades
6. Appropriate sized Endotracheal tubes
7. Equipment and drugs for resuscitation
8. Suxamethonium for emergency use in airway control
METHODS:
Pre-operative preparation
Patients were assessed pre-operatively, procedure was explained to the patient and informed 
consent obtained. They were assessed with particular attention for any contraindications. The tests 
for recovery and the importance of strictly following instructions were emphasized.
Premedication:
All the patients received Glycopyrrolate 5µg/Kg premedication and 
Fentanyl 2µg/Kg analgesia fifteen minutes before induction.
Conduct of anesthesia:
On arrival of the patient in the operating room, monitors like pulseoximetry, Non invasive 
BP  and  ECG  were  connected  and  baseline  values  of  HR,  BP  and  SpO2  were  recorded.  An 
intravenous access was obtained in the nondominant arm. 
Both the groups were induced with Propofol 2mg/Kg I.V. An appropriate sized Laryngeal 
Mask Airway was introduced and its correct position confirmed. No muscle relaxants were used. In 
case of any movement by the patient, an additional bolus of Propofol 0.5mg/Kg was given.
PROPOFOL GROUP:
Immediate post induction, this group of patients received a continuous infusion of Propofol 
from a syringe pump.(B Braun Melsungen ‘S’ series) according to the following scheme:-
–12 mg/kg/h x 10 min (200 mcg/kg/min)
–10 mg/kg/h x 20 min (167 mcg/kg/min)
–8 mg/kg/h x 1 h   (133 mcg/kg/min)
–6 mg/kg/h maintenance (100 mcg/kg/min)
In addition, they were connected to the Bain breathing circuit with 66% Nitrous oxide and 
33% Oxygen. The patient spontaneously ventilated throughout the procedure. Any spontaneous 
movement was tackled with a 20mg bolus of Propofol.
ISOFLURANE GROUP:
Immediate post induction, this group received Isoflurane (Penlon Sigma Delta vaporizer) in 
66%  Nitrous  oxide  and  33%  Oxygen  through  the  Bain  breathing  circuit.  The  percentage  of 
Isoflurane  was  titrated  in  0.2% increments  or  decrements  according  to  patient  response.  The 
patients were allowed to ventilate spontaneously. An increase in the depth of respiration warranted 
an increase in Isoflurane concentration and vice versa.
Monitoring:
Throughout the procedure, Non invasive BP and HR were monitored every 5 minutes; ECG 
and SpO2 were monitored continuously till recovery.
Recovery:
In both groups, the maintenance agent was discontinued once the last skin suture was in 
place. The time of discontinuing the agent was taken as ‘time zero’ to calculate the recovery times. 
The time till  Aldrete score becomes  ≥9 is taken as the time to Phase I recovery.  The time till 
PADSS score ≥9 is taken as the time to Phase II recovery and home readiness.
Parameters Studied:
TIME TO PHASE I RECOVERY:
This is the time taken from discontinuation of Propofol or Isoflurane to the time when the 
Aldrete score is ≥ 9.
TIME TO PHASE II RECOVERY:
This is the time taken from discontinuation of Propofol or Isoflurane to the time when the 
PADSS score is ≥ 9. It is also taken as the time to Home readiness.
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OBSERVATION AND RESULTS:
The patients included in the study were divided into two groups consisting of 20 patients 
each.
Group P (n = 20) received Propofol maintenance
Group I (n = 20) received Isoflurane maintenance
Table 1
Mean age (in years) in both the groups studied
Group n Mean (years) SD Result
Group P 20 25.2 6.96
Group I 20 28.6 10.3
NS*
* – Not Significant
The  two  groups  were  similar  with  respect  to  age,  the  difference  was  not  statistically 
significant.
Table 2
Mean weight (Kg) in both groups studied 
Group n Mean 
(Kg)
SD Result
Group P 20 48.25 12.06
Group I 20 53.5 10.53
NS*
* – Not Significant
There was no statistically significant difference between the two groups as regards weight 
distribution.
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Table 3
Sex distribution in both the groups studied
Sex Group P Group I Result
Male 7 8
Female 13 12
NS*
* – Not Significant
There was no statistically significant  difference between the two groups as regards  sex 
distribution.
Table 4
Duration of surgery (mins)
Group n Mean (mins) SD Result
Group P 20 39.25 16.49
Group I 20 41.25 12.23
NS*
* – Not Significant
There was no statistically significant difference in duration of surgery between the
twogroups
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Table 5
Time to Phase I recovery
Group n Mean (mins) SD Result
Group P 20 10.7 2.89
Group I 20 11 2.15
NS*
* – Not Significant
The time up to Phase I recovery was not statistically significant between the two groups.
Table 6
Time to Phase II recovery
Group n Mean (mins) SD Result
Group P 20 30.75 8.78
Group I 20 56 22.69
P < 0.01
P < 0.05 – Significant
P < 0.01 – Highly significant
There was a statistically significant difference in the time up to ‘Home readiness’ between 
the two groups. The time up to Phase II recovery was significantly shorter with Propofol than with 
Isoflurane.
DISCUSSION
Anaesthesia  for  Day  surgery  demands  high-quality  anaesthesia,  maximal  safety, 
minimal side-effects and rapid recovery. These requirements may point to local or regional 
anaesthesia  as  a  first  choice  when  feasible.  However,  when  general  anaesthesia  is 
required, as is often the case, the characteristics of the ideal anaesthetic technique are 
that induction should be rapid and swift, maintenance should be physiologically stable with 
readily adjustable  anaesthetic depth,  and the recovery should be rapid and complete, 
allowing early return to normal activities.
Propofol is a short-acting intravenous anaesthetic agent used for the induction as well as 
maintenance  of  general  anaesthesia.  Awakening  is  more  rapid  and  complete  than  that  after 
induction of anaesthesia with all other drugs.1, 2, 3 
With Propofol  anaesthesia,  the laryngeal  reflexes are  stable which aids  in using the Laryngeal 
Mask Airway. This   has popularised the use of the Laryngeal Mask Airway in these patients.3 
LMA requires a lower level of depth of anaesthesia and the incidence of post operative sore throat 
is very low when compared with tracheal intubation.
 The  more rapid return  of  consciousness  with  minimal  residual  central  nervous system 
effects is one of the most important advantages of Propofol.
 Isoflurane is a very stable inhalational agent and shows very low solubility in blood and 
body tissues. It undergoes minimal metabolism and is largely eliminated unchanged through the 
lungs.  Throughout  maintenance  of  anaesthesia,  a  high  proportion  of  the  Isoflurane  inspired  is 
eliminated by the lungs. Because of its low solubility, recovery from Isoflurane anaesthesia in man 
is rapid.3 LMA is preferred over Tracheal tube for GA in Day care patients.
Joshi,16 Girish P., MB BS, MD, FFARCSI; Inagaki, Yoshimi, MD et al;  Molloy, Mary E, 
Buggy, Donal J, Scanlon, Patrick in their study on using the Laryngeal Mask Airway concluded 
that it is ideal for Daycase anaesthesia. Figueredo,15 Eduardo, MD,; Vivar-Diago, Miguel, MD,; 
Muñoz-Blanco, Francisco, MD, found that post operative throat discomfort following anaesthesia 
using  laryngeal  mask  depends  on  the  type  of  ventilation.  Spontaneous  ventilation  causes  less 
discomfort than controlled ventilation. McCrory,17 Connail R., MB FFARCSI; McShane, Alan J., 
BSC  FRCPI  FFARCSI  in  a  study comparing  non  premedicated  and  premedicated  patients  in 
ambulatory surgery,  concluded that reflux of gastric contents occurs only in  non premedicated 
patients. With adequate premedication, reflux or micro aspiration did not occur. 
The use of Laryngeal mask airway for our study was based on the above studies.
Recovery  following  Propofol  was  not  dependent  on  the  time  duration  of  surgery.  In 
contrast,  with Isoflurane,  the recovery was prolonged after  long duration surgeries as noted by 
Ebert,7 Thomas J., M.D., Ph.D.; Robinson, Brian J., Ph.D.; Uhrich, Toni D., M.S.; Mackenthun, 
Arden, Ph.D.; Pichotta, Philip J., B.S. in their study. This may be explained by the mechanism of 
recovery from either of these drugs. In Propofol, though redistribution occurs, the major reason for 
the rapid recovery is rapid metabolism. Even in prolonged infusions, rapid metabolic clearance 
when the infusion is discontinued ensures that drug that returns from tissue storage sites to the 
circulation is not available to retard the decrease in plasma concentrations of the drug.  In contrast, 
Isoflurane undergoes negligible metabolism and all the inhaled agent must exit via the lungs. In 
prolonged anaesthesia  with higher  concentrations,  accumulation  of  Isoflurane can occur  in  the 
adipose tissues leading to possible delayed recovery.  To overcome this  confounding factor,  we 
chose short procedures lasting not more than 90 minutes in the study.
Target  Controlled  Infusions  which  use  computer  programmes  to  predict  the  plasma 
concentrations are the best method to infuse Propofol for TIVA. But the algorithms used in these 
pumps are based on the Caucasian race and may not be applicable in our patients. Manual stepped 
infusions are a simple yet effective alternate method to infuse Propofol for TIVA. Sear, J. W.; 
Glen, J. B.14 in their study found that manual stepped infusions of Propofol based on patient weight 
were able to produce adequate plasma Propofol levels and uneventful surgery. This was the basis 
of using stepped infusions in our study. Even with the stepped infusions, some of the patients had 
involuntary movements requiring bolus doses of Propofol. 
In this study we found that the home readiness following Propofol TIVA was earlier than 
Isoflurane. This is in concurrence with the study by Boldt,11 Joachim, MD; Jaun, Norbert, MD; 
Kumle,  Bernhard,  MD;  Heck,  Martin,  MD;  Mund,  Klaus.  Ebert,7 Thomas  J.,  M.D.,  Ph.D.; 
Robinson, Brian J., Ph.D.; Uhrich, Toni D., M.S.; Mackenthun, Arden, Ph.D.; Pichotta, Philip J., 
B.S.  compared  the  recovery  of  Propofol,  Isoflurane  and  Sevoflurane.  They  found  a  quicker 
recovery  with  Propofol  (86.4  mins)  when  compared  to  Isoflurane  (101.5  mins).  The  longer 
`recovery times in comparison to our study may be due to the longer duration of surgery (>120 
mins). Dexter,10 Franklin, M.D., Ph.D.; Tinker, John H., M.D. also found Propofol to be better.
Vincent,  Robert  D.,  Jr.,  M.D.;  Syrop,  Craig  H.,  M.D.;  VanVoorhis,  Bradley  J.,  M.D.; 
Chestnut, David H., M.D.; Sparks, Amy E.T., Ph.D; McGrath, Joan M., M.D.; Choi, Won W., 
M.D.; Bates, James N., M.D. Ph.D.; Penning, Donald H., M.D. found no appreciable difference 
between Propofol and Isoflurane in their study with regards to duration. But the incidence of Post 
operative nausea vomiting was minimal with Propofol. Hence the quality of recovery was better 
with  Propofol.  Ashworth9,  Julie,  MB BS,  FRCA; Smith,  Ian,  BSc,  MB BS,  FRCA too  found 
Propofol to be no better than Isoflurane with respect to recovery.
Juvin,12 Philippe,  MD; Servin,  Frédérique,  MD;  Giraud,  Olivier,  MD;  Desmonts,  Jean-
Marie,  MD  found  Propofol  and  Isoflurane  to  have  same  recovery  times  in  older  people  and 
attributed this to the lipid solubility of Propofol and the higher percentage of body fat in this group 
of patients.
Rowbotham,18 D. J.; Peacock, J. E.; Jones, R. M.; Speedy, H. M.; Sneyd, J. R.; Morris, R. 
W.; Nolan, J. P.; Jolliffe, D.; Lang, G. found that recovery was more rapid in the Isoflurane group, 
although clinically the difference was insignificant. Nausea was more frequent in the Isoflurane 
group than Propofol group but there was no difference in the incidence of emesis. Moffat, 6 A.; 
Cullen, P. M. too found recovery from Isoflurane to be quicker than Propofol. But in this study it 
was noted that Propofol group has a better recovery than the Isoflurane group.
Though my study took into account only the time duration till  recovery,  the quality of 
recovery was much better with Propofol. The incidence of Post Operative Nausea and Vomiting, 
one of the most distressing after effects of General Anaesthesia was nil when Propofol was used as 
maintenance  agent.  Isoflurane  has  some  analgesic  properties.  But  since  a  potent  opioid  like 
Fentanyl was used and since the surgeries were ‘minor’, this property of Isoflurane did not have 
any impact on the results.
One  important  aspect  not  considered  in  this  study is  the  cost  factor.8 This  is  next  to 
impossible to analyse because the study is conducted in a Government institution where the patient 
care is totally free.  All the drugs are provided free of cost to the patient. Many studies comparing 
the costs of the Propofol and Isoflurane conclude in favour of Isoflurane. But they don’t compare 
the overall  cost of high dependency unit stay,  qualified personnel and the drug cost to control 
PONV. 
                                    SUMMARY
Early recovery of psychomotor functions and fewer postoperative side effects, such as nausea 
and vomiting, leads to earlier discharge from the PACU and from the hospital. The use of a TIVA 
regimen may be an important step toward fast-track eligibility and shortening of PACU stay. This may 
result  in  increased efficacy in  busy surgical  centers.  The  anesthetic  depth  was similar  both in  the 
propofol group and  the Isoflurane group. Occasionally Propofol was associated with some purposeful 
movements but was not significant enough to  delay surgery.  Similar problems have been reported 
previously with  Propofol  in  some studies.  These  are  probably related  to  the  complex  relationship 
between the delivered concentration over time and the resultant blood levels. It may also be due to the 
wide variability in patient responses at a given plasma concentration of Propofol. This explains the 
requirement for bolus administration in some of our patients. 
In  spontaneously  breathing  patients,  inadequate  anesthesia  is  manifested  by  purposeful 
movements, which allows corrective action to be taken promptly. As a result, awareness is unlikely, 
and none of our patients recalled intraoperative events. Postoperative pain was well controlled by the 
combination  of  non  steroidal  anti  inflammatory  drugs  and  local  anesthetic  infiltration;  additional 
analgesia was rarely required. Since Fentanyl has been used as an analgesic adjuvant in both groups, 
there was no difference in the severity of postoperative pain in both the groups. . Both Propofol and 
Isoflurane seemed to be acceptable agents for spontaneously breathing anesthetized patients, allowing 
excellent control of the depth of anesthesia without obvious problems. Nevertheless, Propofol did result 
in more rapid intermediate recovery when compared to Isoflurane.
CONCLUSION
On comparing  the recovery time and home readiness  in  Ambulatory Anaesthesia  using 
Propofol as a Total Intravenous Venous Anaesthesia agent and inhalational maintenance technique 
with Isoflurane, it was found that:-
• Propofol as a sole agent had a quicker recovery
• Phase I recovery of both the groups were comparable
• Phase  II  recovery  with  Propofol  TIVA was  much  shorter  than  Isoflurane  maintenance 
anaesthesia.
• The earlier  Home Readiness in TIVA using Propofol makes it  more advantageous than 
Isoflurane maintenance in day case surgeries.
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PROFORMA
DEPARTMENT OF ANESTHESIOLOGY
MADRAS MEDICAL COLLEGE, CHENNAI
TO COMPARE THE RECOVERY TIMES OF PROPOFOL 
OR ISOFLURANE IN DAY CASE PROCEDURES.
S.No. IP No: Date
Name:  Age: Sex:
Weight:  Allergies:
Diagnosis:
Plan:
Co Existing Medical Illness: ( )
DM HT  PT BA IHD  Seizures Hypothyroid
ASA:
Preoperative Investigations:
Blood Sugar:  Blood Urea:
Serum Creatinine: Serum Electrolytes:
CXR: ECG:
Airway: MPC
Premedication:
Inj Glycopyrrolate IV (5micg/Kg)
Inj Fentanyl IV (2micg/Kg)
Induction:
Propofol Initial bolus 2mg/Kg IV
Group ( )
Propofol
-12mg/Kg/h x 10min (200mcg/Kg/min)
-10mg/Kg/h x 20min (167mcg/Kg/min)
-8mg/Kg/h x 1h (133mcg/Kg/min)
-6mg/Kg/h maintenance (100mcg/Kg/min)
Isoflurane
Titrated doses
Size of LMA:
Duration of Procedure:
Time since discontinuing Propofol / Isoflurane to recovery
Phase I (Aldrete Score ≥ 9)
Phase II (PADS Score ≥ 9)

